INVIVOGEN
🏢 View company profile →6Patents
6Active
6Granted
47Portfolio score
Filing activity: Feb 22, 2013 → Dec 28, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9295732B2 | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists | Human Necessities | 23 | Active |
| US10011630B2 | Cyclic dinucleotides for cytokine induction | Chemistry; Metallurgy | 14 | Active |
| US9458184B2 | Compositions of TLR7 and/or TLR8 agonists conjugated to lipids | Chemistry; Metallurgy | 2 | Active |
| US11730817B2 | Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine induction | Human Necessities | 0 | Active |
| US9567336B2 | Conjugated TLR7 and/or TLR8 and TLR2 agonists | Chemistry; Metallurgy | 0 | Active |
| US9637538B2 | Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.